Tags

Type your tag names separated by a space and hit enter

Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Metab Syndr Relat Disord 2009; 7(5):427-34MS

Abstract

BACKGROUND

Metabolic syndrome has become a public health challenge worldwide. The aim of this study was to determine the prevalence of and risk factors for metabolic syndrome among adults in the Mediterranean region of Turkey.

METHODS

This study included a total of 767 people from 20 to 83 years old from 4 provinces calculated with respect to results of the 2000 census. People from the city centers, districts, and villages were selected by a stratified sampling method. Personal histories were recorded. Weight, height, and waist and hip circumferences were measured. Blood samples were obtained to determine glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides. Components of metabolic syndrome were modified from both Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria.

RESULTS

The prevalence of metabolic syndrome was 34.6% (male, 31.2%; female, 37.3%) (P > 0.05) and 28.8% (male, 23.1%; female, 33.5% (P < 0.01) according to IDF criteria and ATP III, respectively. The highest prevalence of metabolic syndrome was present in subjects aged 60-69 years; in obese people (43.2%, P < 0.001); in Hatay province (36.5%, P < 0.001); and in districts (32.2%, P > 0.05). The prevalence of metabolic syndrome criteria in all 4 provinces was as follows: type 2 diabetes mellitus, 15%; hypertension, 41.4%; obesity, 44.1%; abdominal obesity, 56.8%; low HDL-C, 34.1%; hypertriglyceridemia, 35.9%; and high LDL-C, 27.4%.

CONCLUSIONS

The high prevalence of metabolic syndrome in this region is an important public health problem that may cause an increase in mortality. Urgent preventive measurements should be implemented.

Authors+Show Affiliations

Department of Internal Medicine, Erciyes University Medical Faculty, Kayseri 38039, Turkey.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19754305

Citation

Gündogan, Kürsat, et al. "Prevalence of Metabolic Syndrome in the Mediterranean Region of Turkey: Evaluation of Hypertension, Diabetes Mellitus, Obesity, and Dyslipidemia." Metabolic Syndrome and Related Disorders, vol. 7, no. 5, 2009, pp. 427-34.
Gündogan K, Bayram F, Capak M, et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord. 2009;7(5):427-34.
Gündogan, K., Bayram, F., Capak, M., Tanriverdi, F., Karaman, A., Ozturk, A., ... Yazici, C. (2009). Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metabolic Syndrome and Related Disorders, 7(5), pp. 427-34. doi:10.1089/met.2008.0068.
Gündogan K, et al. Prevalence of Metabolic Syndrome in the Mediterranean Region of Turkey: Evaluation of Hypertension, Diabetes Mellitus, Obesity, and Dyslipidemia. Metab Syndr Relat Disord. 2009;7(5):427-34. PubMed PMID: 19754305.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. AU - Gündogan,Kürsat, AU - Bayram,Fahri, AU - Capak,Mehmet, AU - Tanriverdi,Fatih, AU - Karaman,Ahmet, AU - Ozturk,Ahmet, AU - Altunbas,Hasan, AU - Gökce,Cumali, AU - Kalkan,Ali, AU - Yazici,Cevad, PY - 2009/9/17/entrez PY - 2009/9/17/pubmed PY - 2009/12/18/medline SP - 427 EP - 34 JF - Metabolic syndrome and related disorders JO - Metab Syndr Relat Disord VL - 7 IS - 5 N2 - BACKGROUND: Metabolic syndrome has become a public health challenge worldwide. The aim of this study was to determine the prevalence of and risk factors for metabolic syndrome among adults in the Mediterranean region of Turkey. METHODS: This study included a total of 767 people from 20 to 83 years old from 4 provinces calculated with respect to results of the 2000 census. People from the city centers, districts, and villages were selected by a stratified sampling method. Personal histories were recorded. Weight, height, and waist and hip circumferences were measured. Blood samples were obtained to determine glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides. Components of metabolic syndrome were modified from both Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria. RESULTS: The prevalence of metabolic syndrome was 34.6% (male, 31.2%; female, 37.3%) (P > 0.05) and 28.8% (male, 23.1%; female, 33.5% (P < 0.01) according to IDF criteria and ATP III, respectively. The highest prevalence of metabolic syndrome was present in subjects aged 60-69 years; in obese people (43.2%, P < 0.001); in Hatay province (36.5%, P < 0.001); and in districts (32.2%, P > 0.05). The prevalence of metabolic syndrome criteria in all 4 provinces was as follows: type 2 diabetes mellitus, 15%; hypertension, 41.4%; obesity, 44.1%; abdominal obesity, 56.8%; low HDL-C, 34.1%; hypertriglyceridemia, 35.9%; and high LDL-C, 27.4%. CONCLUSIONS: The high prevalence of metabolic syndrome in this region is an important public health problem that may cause an increase in mortality. Urgent preventive measurements should be implemented. SN - 1557-8518 UR - https://www.unboundmedicine.com/medline/citation/19754305/Prevalence_of_metabolic_syndrome_in_the_Mediterranean_region_of_Turkey:_evaluation_of_hypertension_diabetes_mellitus_obesity_and_dyslipidemia_ L2 - https://www.liebertpub.com/doi/full/10.1089/met.2008.0068?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -